National Planning Corporation’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,342
| Closed | -$289K | – | 610 |
|
|
2017
Q3 | $289K | Buy |
3,342
+632
| +23% | +$54.7K | 0.02% | 539 |
|
|
2017
Q2 | $211K | Buy |
+2,710
| New | +$211K | 0.02% | 660 |
|
|
2016
Q1 | – | Sell |
-16,338
| Closed | -$792K | – | 737 |
|
|
2015
Q4 | $792K | Buy |
16,338
+12,737
| +354% | +$617K | 0.06% | 295 |
|
|
2015
Q3 | $259K | Sell |
3,601
-13,940
| -79% | -$1M | 0.02% | 495 |
|
|
2015
Q2 | $1.37M | Buy |
17,541
+11,595
| +195% | +$906K | 0.12% | 171 |
|
|
2015
Q1 | $416K | Buy |
5,946
+2,586
| +77% | +$181K | 0.04% | 407 |
|
|
2014
Q4 | $215K | Sell |
3,360
-555
| -14% | -$35.5K | 0.02% | 641 |
|
|
2014
Q3 | $207K | Buy |
+3,915
| New | +$207K | 0.02% | 656 |
|
|
2014
Q2 | – | Sell |
-4,440
| Closed | -$214K | – | 773 |
|
|
2014
Q1 | $214K | Buy |
+4,440
| New | +$214K | 0.02% | 628 |
|